Cytotopic (Cyto-) IL-15 as a New Immunotherapy for Prostate Cancer: Recombinant Production in Escherichia coli and Purification

Interleukin-15 (IL-15) is a cytokine previously suggested as a potential immunotherapy for cancer treatment. IL-15 can effectively reduce tumor growth in many preclinical tumor models including prostate cancer. This is due to its ability to expand and activate immune cells, such as CD8(+) T cells an...

Descripción completa

Detalles Bibliográficos
Autores principales: Esteves, Ana M., Papaevangelou, Efthymia, Smolarek, Dorota, Dasgupta, Prokar, Galustian, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578882/
https://www.ncbi.nlm.nih.gov/pubmed/34778376
http://dx.doi.org/10.3389/fmolb.2021.755764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578882/
https://www.ncbi.nlm.nih.gov/pubmed/34778376
http://dx.doi.org/10.3389/fmolb.2021.755764

Ejemplares similares